185 related articles for article (PubMed ID: 29789011)
1. Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies.
Ugwu DI; Okoro UC; Mishra NK; Okafor SN
Lipids Health Dis; 2018 May; 17(1):120. PubMed ID: 29789011
[TBL] [Abstract][Full Text] [Related]
2. An experimental study on amelioration of dyslipidemia-induced atherosclesis by Clematichinenoside through regulating Peroxisome proliferator-activated receptor-α mediated apolipoprotein A-I, A-II and C-III.
Liu C; Guo Q; Lu M; Li Y
Eur J Pharmacol; 2015 Aug; 761():362-74. PubMed ID: 25979856
[TBL] [Abstract][Full Text] [Related]
3. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
Fruchart JC; Duriez P
Drugs Today (Barc); 2006 Jan; 42(1):39-64. PubMed ID: 16511610
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation.
Hassan RM; Aboutabl ME; Bozzi M; El-Behairy MF; El Kerdawy AM; Sampaolese B; Desiderio C; Vincenzoni F; Sciandra F; Ghannam IAY
Bioorg Chem; 2021 Oct; 115():105170. PubMed ID: 34332233
[TBL] [Abstract][Full Text] [Related]
5. HVC1 ameliorates hyperlipidemia and inflammation in LDLR
Cheon SY; Chung KS; Lee KJ; Choi HY; Ham IH; Jung DH; Cha YY; An HJ
BMC Complement Altern Med; 2017 Apr; 17(1):222. PubMed ID: 28427397
[TBL] [Abstract][Full Text] [Related]
6. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
[TBL] [Abstract][Full Text] [Related]
7. Hypolipidemic effect of XH601 on hamsters of Hyperlipidemia and its potential mechanism.
Zhao MJ; Wang SS; Jiang Y; Wang Y; Shen H; Xu P; Xiang H; Xiao H
Lipids Health Dis; 2017 May; 16(1):85. PubMed ID: 28464894
[TBL] [Abstract][Full Text] [Related]
8. Gemfibrozil Induces Anemia, Leukopenia and Reduces Hematopoietic Stem Cells via PPAR-α in Mice.
Estrela GR; Arruda AC; Torquato HFV; Freitas-Lima LC; Perilhão MS; Wasinski F; Budu A; Fock RA; Paredes-Gamero EJ; Araujo RC
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708962
[TBL] [Abstract][Full Text] [Related]
9. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
10. Hypolipidemic 2-[4-(1,1-dimethylethyl)phenyl]-4H-3,1-benzoxazin-4-ones. Structure-activity relationships of a novel series of high-density lipoprotein elevators.
Fenton G; Newton CG; Wyman BM; Bagge P; Dron DI; Riddell D; Jones GD
J Med Chem; 1989 Jan; 32(1):265-72. PubMed ID: 2909740
[TBL] [Abstract][Full Text] [Related]
11. Structural simplification and bioisostere principle lead to Bis-benzodioxole-fibrate derivatives as potential hypolipidemic and hepatoprotective agents.
Xie Y; Liu J; Shi Y; Wang B; Wang X; Wang W; Sun M; Xu X; Cheng L; He S
Bioorg Chem; 2021 Dec; 117():105454. PubMed ID: 34740054
[TBL] [Abstract][Full Text] [Related]
12. Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-α in hypercholesterolemic rats induced with a high-cholesterol diet.
Wan CW; Wong CN; Pin WK; Wong MH; Kwok CY; Chan RY; Yu PH; Chan SW
Phytother Res; 2013 Apr; 27(4):545-51. PubMed ID: 22674675
[TBL] [Abstract][Full Text] [Related]
13. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
14. Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver.
Roglans N; Bellido A; Rodríguez C; Cabrero A; Novell F; Ros E; Zambón D; Laguna JC
Clin Pharmacol Ther; 2002 Dec; 72(6):692-701. PubMed ID: 12496750
[TBL] [Abstract][Full Text] [Related]
15. Novel peroxisome proliferator-activated receptor alpha agonists lower low-density lipoprotein and triglycerides, raise high-density lipoprotein, and synergistically increase cholesterol excretion with a liver X receptor agonist.
Mukherjee R; Locke KT; Miao B; Meyers D; Monshizadegan H; Zhang R; Search D; Grimm D; Flynn M; O'Malley KM; Zhang L; Li J; Shi Y; Kennedy LJ; Blanar M; Cheng PT; Tino J; Srivastava RA
J Pharmacol Exp Ther; 2008 Dec; 327(3):716-26. PubMed ID: 18799592
[TBL] [Abstract][Full Text] [Related]
16. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
17. The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression.
Kim HJ; Moon JH; Kim HM; Yun MR; Jeon BH; Lee B; Kang ES; Lee HC; Cha BS
Metabolism; 2014 Jan; 63(1):112-9. PubMed ID: 24139096
[TBL] [Abstract][Full Text] [Related]
18. Ursolic acid is a PPAR-α agonist that regulates hepatic lipid metabolism.
Jia Y; Bhuiyan MJ; Jun HJ; Lee JH; Hoang MH; Lee HJ; Kim N; Lee D; Hwang KY; Hwang BY; Choi DW; Lee SJ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5876-80. PubMed ID: 21855333
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
[TBL] [Abstract][Full Text] [Related]
20. Amide-linked Ethanolamine Conjugate of Gemfibrozil as a Profound HDL Enhancer: Design, Synthesis, Pharmacological Screening and Docking Study.
Rai H; Dhaneshwar SS
Curr Drug Discov Technol; 2015; 12(3):155-69. PubMed ID: 26285608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
